Product Information
HALOPERIDOL DEC 100 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $16.1395 per ML under NDC 63323047101. Its NADAC has been published 539 times since Nov 28, 2013.
FDA first approved this application on Dec 19, 1997. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323047101
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA074893FDA Approved
12/19/1997
TE Code
AO
On Market Since
7/12/2000
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has been published 539 times since Nov 28, 2013, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.1395 per ML |
|---|---|
| All-time high | $53.3194 (Apr 13, 2016) |
| All-time low | $15.6000 (Jan 19, 2022) |
| 52-week high | $18.4466 |
| 52-week low | $16.0162 |
| Median price | $24.6873 |
| Average price | $31.5338 |
| Largest weekly change | +32.2% (Oct 19, 2022) |
| Weeks tracked | 539 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HALOPERIDOL DECANOATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 100 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 100 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $16.1395 per ML (NDC 63323047101), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 100 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has declined 60.6%. It has been tracked across 539 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 100 MG/ML VIAL?
Since Nov 28, 2013, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has ranged from a low of $15.6000 (Jan 19, 2022) to a high of $53.3194 (Apr 13, 2016), with a median of $24.6873 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 100 MG/ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 100 MG/ML VIAL, is $7.5241 per ML — about 53% below HALOPERIDOL DEC 100 MG/ML VIAL.
Who manufactures HALOPERIDOL DEC 100 MG/ML VIAL?
HALOPERIDOL DEC 100 MG/ML VIAL (NDC 63323047101) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.